Viewing StudyNCT00027625



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00027625
Status: COMPLETED
Last Update Posted: 2018-06-27
First Post: 2001-12-07

Brief Title: Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-01-28
Start Date Type: ACTUAL
Primary Completion Date: 2005-03-17
Primary Completion Date Type: ACTUAL
Completion Date: 2005-11-01
Completion Date Type: ACTUAL
First Submit Date: 2001-12-07
First Submit QC Date: January 26 2003
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-06-25
Last Update Post Date: 2018-06-27
Last Update Post Date Type: ACTUAL